FGD4 Gene CMT4H NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Neuropathy
The FGD4 Gene CMT4H NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying Charcot-Marie-Tooth disease type 4H, a rare inherited neurological disorder affecting peripheral nerves. This sophisticated genetic analysis provides crucial insights for patients and families dealing with progressive neuromuscular symptoms, enabling accurate diagnosis and personalized treatment planning.
What Does the FGD4 Gene CMT4H Test Detect?
This advanced genetic test specifically targets mutations in the FGD4 gene, which encodes the FGD1-related F-actin-binding protein. The test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the entire FGD4 gene, identifying:
- Point mutations and single nucleotide variants
- Small insertions and deletions
- Copy number variations
- Pathogenic variants associated with CMT4H
Who Should Consider This Genetic Test?
This specialized genetic testing is recommended for individuals presenting with symptoms suggestive of Charcot-Marie-Tooth disease or hereditary motor and sensory neuropathy, including:
- Progressive muscle weakness in feet and hands
- Sensory loss in extremities
- Foot deformities such as high arches or hammertoes
- Reduced or absent deep tendon reflexes
- Family history of similar neurological symptoms
- Children with delayed motor development
- Individuals with unexplained peripheral neuropathy
Key Benefits of FGD4 Genetic Testing
Undergoing the FGD4 Gene CMT4H NGS Genetic DNA Test offers numerous advantages for patients and healthcare providers:
- Definitive Diagnosis: Provides conclusive genetic evidence for CMT4H
- Early Intervention: Enables proactive management strategies
- Family Planning: Informs reproductive decisions and genetic counseling
- Personalized Care: Guides targeted treatment approaches
- Prognostic Information: Helps predict disease progression
- Research Contribution: Advances understanding of rare neurological disorders
Understanding Your Test Results
Our comprehensive genetic analysis provides detailed insights into your FGD4 gene status:
- Positive Result: Indicates the presence of pathogenic FGD4 mutations associated with CMT4H
- Negative Result: Suggests no detectable FGD4 mutations, though other genetic causes should be considered
- Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications
- Carrier Status: Determines if you carry a single copy of a mutated gene
All results include detailed interpretation by our board-certified genetic specialists and recommendations for next steps.
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Pre-Test Requirements
Before undergoing the FGD4 Gene CMT4H NGS Genetic DNA Test, we recommend:
- Complete clinical history documentation
- Genetic counseling session with our specialists
- Development of detailed family pedigree chart
- Discussion of testing implications and potential outcomes
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, high-quality care regardless of your location.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary neuropathy conditions impact your quality of life. The FGD4 Gene CMT4H NGS Genetic DNA Test provides the clarity needed to make informed healthcare decisions and plan for the future. Our team of neurological genetics specialists is ready to guide you through every step of the testing process.
Ready to schedule your genetic test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward definitive answers and personalized neurological care.
